Use of luteinizing hormone (LH) and chorionic gonadotrophin (hCG) for proliferation of neural precursor cells and neurogenesis

摘要

A pharmaceutical composition comprising human chorionic gonadotropin (hCG) or luteinizing hormone (LH) for use in treating a neurodegenerative disease or condition in a mammal by lapotenciación neurogenesis, wherein the treatment comprises administration coneritropoyetina combination ( EPO).